Finding the Right Keys: Using Antibody Therapy to Fight Infectious Diseases

Scientists first identified antibodies as mediators of adaptive immunity in the early 20th century. With the development of hybridoma antibody technology in the 1970s, scientists harnessed the power of antibodies as selective therapeutic agents. Today, antibody therapies treat a plethora of ailments, from drug-resistant infections to emerging pathogens, such as SARS-CoV-2.